Analyst firms · H.C. Wainwright · BNTX
H.C. Wainwright BNTX price target and rating history
BioNTech SE (BNTX) · Health Care
H.C. Wainwright rates BioNTech SE (BNTX) Buy with a $145 price target, as of its latest action on Jun 5, 2025. It has published 5 rating actions on BNTX since August 2021, including 1 upgrade and 0 downgrades. Across 5 firms with a BNTX price target in the last 12 months, the median target is $113.
- Current rating
- Buy
- Price target
- $145
- Median target, all firms
- $113
- Actions on BNTX
- 5
H.C. Wainwright price target on BNTX
Every H.C. Wainwright rating on BNTX
- Jun 5, 2025
- Feb 23, 2022
- Dec 21, 2021
- Nov 10, 2021
- Aug 11, 2021
How other firms rate BNTX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Hold | Oct 8, 2026 | |
| BMO Capital Markets | Market Perform | $105 | Sep 8, 2026 |
| UBS | Buy | $135 | May 27, 2026 |
| Bernstein | Mkt Perform | $96 | May 22, 2026 |
| Leerink Partners | Market Perform | $113 | Feb 2, 2026 |
| Goldman Sachs | Buy | $142 | Jan 16, 2026 |
Questions about H.C. Wainwright and BNTX
- What is H.C. Wainwright's price target for BNTX?
- H.C. Wainwright's latest stated price target for BioNTech SE (BNTX) is $145, from its action on Jun 5, 2025.
- What is H.C. Wainwright's rating on BNTX?
- H.C. Wainwright rates BNTX Buy, a bullish rating, as of Jun 5, 2025.
- When did H.C. Wainwright last change its view on BNTX?
- On Jun 5, 2025, H.C. Wainwright raises its price target to $145 from $134, keeps Buy.
- How does H.C. Wainwright's BNTX target compare with other analysts?
- Across 5 firms with a BNTX price target in the last 12 months, the median target is $113.
More BNTX rating histories
All H.C. Wainwright ratingsBNTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.